HOME

What we provide
is essential.

en

Discover Juvise Pharmaceuticals

Read More

Our therapeutic areas

Read More

Products with high added value

Read More

News

Juvisé Pharmaceuticals successfully completes a €400M refinancing following the acquisition of the worldwide rights of Pylera®

Juvisé Pharmaceuticals successfully completes a €400M refinancing following the acquisition of the worldwide rights of Pylera®

03/03/2023

Read the article

Interview of Frédéric Mascha, Founder and President of Juvisé Pharmaceuticals, by the French economic journalist, Nicolas Doze, on BFM Business channel
Interview of Frédéric Mascha, Founder and President of Juvisé Pharmaceuticals, by the French economic journalist, Nicolas Doze, on BFM Business channel

14/12/2020

Watch video

Juvisé Pharmaceuticals successfully syndicated its EUR 213 million financing in less than one month
Juvisé Pharmaceuticals successfully syndicated its EUR 213 million financing in less than one month

04/02/2020

Read the article

The French speciality pharmaceutical company, Juvisé Pharmaceuticals acquires two oncology products from AstraZeneca
The French speciality pharmaceutical company, Juvisé Pharmaceuticals acquires two oncology products from AstraZeneca

20/12/2019

Read the article

Paris office

Paris

28 rue Bayard
75008 Paris
France


Lyon office

Lyon

149 boulevard Bataille de Stalingrad
69100 Villeurbanne
France


Phone : +33 (0)4 26 29 40 00

Contact Juvisé Pharmaceuticals

Contact

This site is registered on wpml.org as a development site.